Chemistry:Y-23684
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C18H13ClN2O2S |
| Molar mass | 356.82 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Y-23684 is an anxiolytic drug with a novel chemical structure, which is used in scientific research.[1][2] It has similar effects to benzodiazepine drugs, but is structurally distinct and so is classed as a nonbenzodiazepine anxiolytic.
Y-23684 is a nonselective partial agonist at GABAA receptors. It has primarily anxiolytic and anticonvulsant effects, with sedative and muscle relaxant effects only appearing at higher doses. It produces little ataxia or potentiation of other sedatives such as ethanol or barbiturates when compared to the benzodiazepines diazepam and clobazam in animal tests.[3][4][5]
Y-23684 has a favourable pharmacological profile, producing strong anxiolytic and moderate anticonvulsant effects at low doses that cause little or no sedative side effects. It has been proposed for development for human medical use, but has not yet gone beyond animal tests.[6]
References
- ↑ "Studies on the synthesis of condensed pyridazine derivatives. IV. Synthesis and anxiolytic activity of 2-aryl-5,6-dihydro-(1)benzothiepino[5,4- c]pyridazin-3(2H)-ones and related compound". Chemical & Pharmaceutical Bulletin 39 (10): 2556–63. October 1991. doi:10.1248/cpb.39.2556. PMID 1687209.
- ↑ "Synthesis and biological activities of optical isomers of 2-(4-chlorophenyl)-5,6-dihydro-(1)benzothiepino[5,4-c]pyridazin-3(2H)-o ne 7-oxide". Chemical & Pharmaceutical Bulletin 40 (1): 117–21. January 1992. doi:10.1248/cpb.40.117. PMID 1349512.
- ↑ "Differential properties of type I and type II benzodiazepine receptors in mammalian CNS neurones". British Journal of Pharmacology 109 (3): 819–25. July 1993. doi:10.1111/j.1476-5381.1993.tb13648.x. PMID 8395299.
- ↑ "The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist". British Journal of Pharmacology 111 (4): 1170–8. April 1994. doi:10.1111/j.1476-5381.1994.tb14868.x. PMID 7913372.
- ↑ "Differences in anxiolytic-like profile of two novel nonbenzodiazepine BZ (omega) receptor agonists on defensive behaviors of mice". Pharmacology, Biochemistry, and Behavior 62 (4): 689–94. April 1999. doi:10.1016/s0091-3057(98)00209-3. PMID 10208374.
- ↑ "Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands". Behavioural Pharmacology 10 (5): 483–95. September 1999. doi:10.1097/00008877-199909000-00007. PMID 10780255.
 |  |
